Protease Inhibitors and Urolithiasis
- 1 July 1997
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (1), 31-33
- https://doi.org/10.1097/00005392-199707000-00007
Abstract
We discuss the specific urological abnormalities associated with protease inhibitor therapy. We report on a human immunodeficiency virus positive patient who was on protease inhibitor therapy and presented with renal colic. The stone passed spontaneously. Stone analysis was not consistent with any known composition of urinary calculus. The positive effects of protease inhibitors in human immunodeficiency virus positive patients mandate that the urological community become familiar with these drugs and the specific urological complications as the use of these drugs becomes widespread.Keywords
This publication has 8 references indexed in Scilit:
- Inhibition of the Protease of Human Immunodeficiency Virus Blocks Replication and Infectivity of the Virus in Chronically Infected MacrophagesThe Journal of Infectious Diseases, 1993
- Antiviral Synergy between Inhibitors of HIV Proteinase and Reverse TranscriptaseAntiviral Chemistry and Chemotherapy, 1993
- HIV-1 Protease Cleaves Actin During Acute Infection of Human T-LymphocytesAIDS Research and Human Retroviruses, 1992
- Fibronectin is a non‐viral substrate for the HIV proteinaseFEBS Letters, 1991
- Calcium‐free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2Proteins-Structure Function and Bioinformatics, 1991
- An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.Proceedings of the National Academy of Sciences, 1990
- Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.Proceedings of the National Academy of Sciences, 1990
- A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle MaturationScience, 1990